Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising number of end stage renal diseases (ESRD) patients
3.2.1.2 Increasing incidence of diabetes
3.2.1.3 Shortage of donor kidneys
3.2.1.4 Favorable reimbursement scenario available for dialysis treatment
3.2.1.5 Growing R&D investments in developed as well as developing countries
3.2.2 Industry pitfalls & challenges
3.2.2.1 Product recalls
3.2.2.2 Complications in the treatment
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Reimbursement scenario
3.6 Technology landscape
3.7 Value chain analysis
3.8 Porter’s analysis
3.9 PESTEL analysis
3.10 Gap analysis
3.11 Future market trends
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Hemodialysis
5.3 Peritoneal dialysis
Chapter 6 Market Estimates and Forecast, By Product and Services, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Services
6.2.1 Chronic dialysis
6.2.2 Acute dialysis
6.3 Consumables
6.3.1 Dialyzers
6.3.2 Catheters
6.3.3 Access products
6.3.4 Concentrates
6.3.5 Other consumables
6.4 Equipment
6.4.1 Dialysis machines
6.4.2 Water treatment systems
6.4.3 Other equipment
Chapter 7 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 In-center dialysis
7.3 Home dialysis
Chapter 8 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Poland
8.3.7 Sweden
8.3.8 Netherlands
8.3.9 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Indonesia
8.4.7 Philippines
8.4.8 Malaysia
8.4.9 Rest of APAC
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Chile
8.5.5 Colombia
8.5.6 Peru
8.5.7 Rest of LATAM
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Israel
8.6.5 Turkey
8.6.6 Egypt
8.6.7 Rest of MEA
Chapter 9 Company Profiles
9.1 AngioDynamics, Inc.
9.2 Asahi Kasei Corporation
9.3 B. Braun Holding GmbH & Co. KG
9.4 Baxter International Inc.
9.5 Becton, Dickinson and Company
9.6 DaVita Inc.
9.7 Dialife SA
9.8 Fresenius SE and Co. KGaA
9.9 JMS Co Ltd
9.10 KAWASUMI LABORATORIES INC
9.11 Medtronic Plc.
9.12 Nikkiso Co. Ltd.
9.13 Nipro Medical Corporation
9.14 Rogosin Institute
9.15 Satellite Healthcare
9.16 Teleflex Incorporated
9.17 Toray Industries Inc.
9.18 U.S. Renal Care, Inc.
